Advanced Solid Tumors With an Alteration of the PIK3CA Gene Active Not Recruiting Phase 1 Trials for Fulvestrant (DB00947)

IndicationStatusPhase
DBCOND0049176 (Advanced Solid Tumors With an Alteration of the PIK3CA Gene)Active Not Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs